by CheckRare Staff | Dec 1, 2023
Andrew Bomback, MD, Columbia University Medical Center, gives an IC-MPGN and C3G overview, two rare inflammatory kidney diseases. Transcription: My name is Andrew Bomback. I am a nephrologist at Columbia University Irving Medical Center, where I...
by CheckRare Staff | Nov 29, 2023
Richard Lewis, MD, Department of Neurology at Cedars-Sinai Medical Center, discusses diagnosing CIDP as well as the revised guidelines used to manage this rare disease. Transcription: There have been guidelines created over the years. Because it’s...
by CheckRare Staff | Nov 28, 2023
Christine Eng, MD, Chief Medical Officer at Baylor Genetics, discusses whole genome sequencing and other forms of genetic testing in diagnosing rare diseases. Transcription: All of the testing that we do really is designed to address unmet patient...
by CheckRare Staff | Nov 27, 2023
Eric Crombez, MD, Chief Medical Officer of Ultragenyx, discusses the latest results from the Phase 2/3 Orbit Study targeting osteogenesis imperfecta. Transcription: Orbit is the name we have given to our ongoing phase 2/3 study. We have been talking...
by CheckRare Staff | Nov 24, 2023
Rick Hawkins, Chief Executive Officer at Lumos Pharma, discusses the OraGrowth212 Clinical Trial testing LUM-201 (ibutamoren) to treat pediatric growth hormone deficiency (PGHD). Transcription: We have a global trial up and running. There are 80...
